Paliperidone Extended Release Tablets for the Prevention of Relapse in Subjects With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
Phase of Trial: Phase III
Latest Information Update: 10 Nov 2014
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2013 Planned end date changed from 1 Nov 2014 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 20 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.